Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:25 PM ET 8-K
Investor Presentation Star Equity Holdings, Inc. STRR

Star Equity Holdings Investor Presentation

Star Equity Holdings, Inc. furnished a formal investor presentation deck dated October 14, 2026, detailing its business operations and strategy as of June 30, 2026. The presentation outlines the company's approach to creating shareholder value through organic growth, acquisitions, and share repurchases.

4:05 PM ET 8-K
Investor Presentation CervoMed Inc. CRVO

CervoMed Investor Presentation

CervoMed Inc. announced that it has updated its corporate presentation containing information about its business, clinical studies, and development plans. The presentation is being made available on the company's website and will be used by management in upcoming meetings and conferences with investors and analysts.

3:41 PM ET 8-K
Investor Presentation High Roller Technologies, Inc. ROLR

High Roller Technologies Investor Presentation

High Roller Technologies, Inc. has updated its corporate investor presentation and filed it as an exhibit to this 8-K. The company intends to use the presentation for upcoming meetings with investors, analysts, and other stakeholders to discuss its business strategy and operations.

12:03 PM ET 8-K
Investor Presentation KiNRG, Inc. BYOP

KiNRG Investor Presentation

KiNRG, Inc. made available a formal investor presentation detailing its HydroThermal Reactor (HTR) technology and its strategy for delivering clean energy to data centers and industrial operations. The presentation was filed under Item 7.01 and is intended for use in meetings with prospective investors and in connection with potential capital-raising activities.

6:44 AM ET 8-K
Investor Presentation Accenture plc ACN

Accenture Investor Presentation

Accenture hosted its 2026 Investor Day, providing a review of FY26 performance and outlining strategic financial ambitions through FY29. The company targets mid-single digit revenue growth in FY27-FY28 and mid-to-high single digit growth in FY29, alongside 10-30 bps of annual operating margin expansion.

5:17 PM ET 8-K
Investor Presentation Upexi, Inc. UPXI

Upexi Investor Presentation

Upexi, Inc. filed its Fall 2026 investor presentation as an exhibit to be used in upcoming investor conferences and meetings. The presentation provides a strategic and operational update for investors and interested parties.

5:01 PM ET 8-K
Investor Presentation Intelligent Bio Solutions Inc. INBS

Intelligent Bio Solutions Investor Presentation

Intelligent Bio Solutions Inc. has furnished a formal investor presentation relating to its business and operations. Additionally, the company's Board of Directors adopted amended and restated bylaws to clarify stockholder voting procedures, specifically regarding the treatment of abstentions and broker non-votes.

4:14 PM ET 8-K
Investor Presentation Castellum, Inc. CTM

Castellum Investor Presentation

Castellum, Inc. announced its participation in the 2026 Maxim Group Growth Summit on October 14, 2026. Management will be meeting with institutional investors in one-on-one sessions during the named conference event.

Counterparty
Maxim Group
9:31 AM ET 8-K
Investor Presentation Crexendo, Inc. CXDO

Crexendo Investor Presentation

Crexendo, Inc. has published a new investor presentation dated October 13, 2026, to its corporate website. The presentation, which was also filed as an exhibit to the SEC Form 8-K, provides updated information for investors and analysts regarding the company's business and strategic outlook.

9:01 AM ET 8-K
Investor Presentation Oncotelic Therapeutics, Inc. OTLC

Oncotelic Therapeutics Investor Presentation

Oncotelic Therapeutics presented details on its PDAOAI platform and hepatocellular carcinoma (HCC) research at the Drug Discovery 2026 conference. The presentations highlighted a four-gene mTOR-related signature associated with patient survival and introduced the 'BIO REBOOT' initiative to support new therapeutic research projects.

Counterparty
Drug Discovery 2026
5:16 PM ET 8-K
Investor Presentation Mobix Labs, Inc MOBX

Mobix Labs Investor Presentation

Mobix Labs, Inc. filed an investor presentation dated October 8, 2026, regarding its national security platform initiative. The presentation was used during an investor update call to provide strategic highlights and operational updates to shareholders.

4:35 PM ET 8-K
Investor Presentation Hydrofarm Holdings Group, Inc. HYFM

Hydrofarm Holdings Group Investor Presentation

Hydrofarm Holdings Group, Inc. filed a formal investor presentation deck dated October 7, 2026, to be used in upcoming meetings with analysts and market participants. Separately, the company entered into a settlement agreement to resolve claims related to a prior engagement, agreeing to issue 300,000 shares of newly designated non-voting convertible preferred stock.

4:07 PM ET 8-K
Investor Presentation CervoMed Inc. CRVO

CervoMed Investor Presentation

CervoMed Inc. has updated its corporate investor presentation, which is being made available on the company's website. The presentation covers the company's business, clinical studies, development plans, and financial position, and will be used by management in upcoming meetings with investors and analysts.

12:11 PM ET 8-K
Investor Presentation Exozymes Inc. EXOZ

Exozymes Investor Presentation

eXoZymes Inc. filed a formal Investor Presentation dated October 6, 2026, to be shared with investment bankers and potential investors. The presentation provides strategic highlights and business updates for the company's current and future stakeholders.

4:16 PM ET 8-K
Investor Presentation Tenax Therapeutics, Inc. TENX

Tenax Therapeutics Investor Presentation

Tenax Therapeutics filed an updated investor presentation detailing strategic changes to its Phase 3 LEVEL-2 clinical trial for TNX-103 in PH-HFpEF. The company is pausing enrollment to amend protocol criteria based on findings from its completed LEVEL trial and has requested a Type C meeting with the FDA to discuss the development path.

4:08 PM ET 8-K
Investor Presentation Braemar Hotels & Resorts Inc. BHR

Braemar Hotels & Resorts Investor Presentation

Braemar Hotels & Resorts announced a definitive agreement to sell the Four Seasons Resort Scottsdale for $372 million as part of its strategic transition to a self-managed REIT. The company also released a comprehensive investor presentation titled 'A New Chapter for Braemar' and provided a 2027 financial outlook following its separation from Ashford Inc.

8:20 AM ET 8-K
Investor Presentation Mission Produce, Inc. AVO

Mission Produce Investor Presentation

Mission Produce is hosting its 2026 Investor Day to unveil a five-year growth strategy targeting mid-single-digit organic sales growth and 300 basis points of margin expansion. The company also introduced a long-term 2035 ambition to double sales and triple Adjusted EBITDA while providing an update on its $100 million stock repurchase program.

Term
5 years

“Mission was built to lead. Over more than 40 years, we built the modern avocado category and created a platform that would be difficult to replicate. Our next chapter is about fully leveraging that platform and compounding the value we deliver to shareholders by growing faster than our markets, expanding margins, converting more earnings into cash and deploying that cash with discipline.”

John Pawlowski, President and Chief Executive Officer
4:36 PM ET 8-K
Investor Presentation Upexi, Inc. UPXI

Upexi Investor Presentation

Upexi, Inc. announced that its Chief Strategy Officer, Brian Rudick, will participate in several investor conferences in October 2026, including the Maxim Growth Summit, the Webull Emerging & Innovative Companies Webinar, and the LD Micro 20th Annual Main Event. The company, which focuses on digital asset treasury management and consumer brands, will conduct presentations and one-on-one investor meetings at these events.

Counterparty
Maxim Group
4:16 PM ET 8-K
Investor Presentation reAlpha Tech Corp. AIRE

reAlpha Tech Investor Presentation

reAlpha Tech Corp. has posted a new investor presentation to its website for use in upcoming meetings and conferences with investors and analysts. The presentation is accessible via the company's investor relations portal and provides updated information for interested parties.

8:48 AM ET 8-K
Investor Presentation Bitmine Immersion Technologies, Inc. BMNR

Bitmine Immersion Technologies Investor Presentation

Bitmine Immersion Technologies published an investor presentation and video transcript delivered by Executive Chairman Tom Lee at the Token2049 Global Conference in Singapore. The filing includes the formal presentation deck and a press release announcing the event under Item 7.01.

Counterparty
Token2049 Global Conference
8:16 AM ET 8-K
Investor Presentation Maia Biotechnology, Inc. MAIA

Maia Biotechnology Investor Presentation

MAIA Biotechnology, Inc. has prepared and posted a new corporate investor presentation and a summary highlighting its operations and performance to its website. Management intends to use these materials for upcoming presentations to investors and analysts starting October 6, 2026.

7:46 AM ET 8-K
Investor Presentation 60 Degrees Pharmaceuticals, Inc. SXTP

60 Degrees Pharmaceuticals Investor Presentation

60 Degrees Pharmaceuticals updated its investor presentation and held a webinar to discuss interim data from its clinical study of tafenoquine for severe babesiosis. The presentation covers clinical context, DSMB feedback from the hospital study, and the regulatory path forward for the treatment.

6:03 AM ET 8-K
Investor Presentation Zscaler, Inc. ZS

Zscaler Investor Presentation

Zscaler is hosting its 2026 Investor Day in New York City to discuss its long-term strategy, AI-driven platform innovation, and its path toward a $10 billion ARR target. In conjunction with the event, the company reaffirmed its financial guidance for the first quarter and full fiscal year 2027.

4:42 PM ET 8-K
Investor Presentation Genie Energy Ltd. GNE

Genie Energy Investor Presentation

Genie Energy Ltd. filed a formal investor presentation deck as an exhibit to be provided to certain investors and made available on its corporate website. The presentation contains forward-looking statements regarding the company's strategic outlook and operations.

4:06 PM ET 8-K
Investor Presentation Serve Robotics Inc. SERV

Serve Robotics Investor Presentation

Serve Robotics Inc. updated its corporate investor presentation to include preliminary unaudited management estimates regarding its cost of revenue for the fiscal year ending December 31, 2026. The presentation highlights the company's commercial Level 4 autonomous robot fleets and its diversified revenue streams across delivery, healthcare, and advertising.

8:30 AM ET 8-K
Investor Presentation Moleculin Biotech, Inc. MBRX

Moleculin Biotech Investor Presentation

Moleculin Biotech, Inc. has filed a formal corporate investor presentation as an exhibit to its 8-K. The presentation, dated October 5, 2026, is being used for corporate updates and has been posted to the company's website. The filing was made under Item 7.01 (Regulation FD Disclosure) to provide current information to investors and analysts.

8:01 AM ET 8-K
Investor Presentation SS Innovations International, Inc. SSII

SS Innovations International Investor Presentation

SS Innovations International, Inc. (SSII) filed an updated October 2026 Company Presentation to be used in communications with shareholders and the investment community. The presentation highlights the company's proprietary surgical robotic system, the SSi Mantra 3, and its vision for affordable surgical robotic solutions.

4:27 PM ET 8-K
Investor Presentation Quantum Computing Inc. QUBT

Quantum Computing Investor Presentation

Quantum Computing Inc. (QUBT) has posted an updated investor presentation to its website and filed it as an exhibit to its 8-K. The presentation highlights the company's room-temperature quantum photonics technology, its $1.3 billion cash position with no debt, and its focus on commercializing quantum products for aerospace, defense, and cybersecurity markets.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.